Learn from the scientific posters presented at the 2021 European Meeting of ISMPP in January and the 17th Annual Meeting of ISMPP in April. Thank you to the ISMPP members who presented posters/oral presentations this year! Find out about the first US Food and Drug Administration (FDA) Notice of Noncompliance for failure to post clinical trial results on ClinicalTrials.gov, as well as an updated PRISMA Statement and a new CONSORT Extension.
FDA Issues Notice of Noncompliance for Lack of Posting Clinical Trial Results
The FDA issued a Notice of Noncompliance to Acceleron Pharma on April 27, 2021, for potential noncompliance with the requirement to submit clinical trial results information for posting on the ClinicalTrials.gov website. This is the first time the FDA has publicly raised the potential for civil monetary penalties and other regulatory actions, such as injunction and/or criminal prosecution, for violating the Final Rule for Clinical Trials Registration and Results Information Submission (42 CFR Part 11), which became effective in 2017. Read the FDA Statement for more information.
Updates Related to PRISMA Statement and CONSORT Extension
The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews was published in the journal Systematic Reviews on March 29, 2021. The PRISMA* 2020 statement replaces the PRISMA 2009 statement and includes a new checklist of 16 reporting items for systematic reviews.
CONSORT Extension for the Reporting of Randomised Controlled Trials Conducted Using Cohorts and Routinely Collected Data (CONSORT-ROUTINE): Checklist with Explanation and Elaboration was published in The BMJ on April 29, 2021. The extension covers key aspects of trials conducted using cohorts or routinely collected data that require specific reporting considerations and includes eight items modified from the CONSORT** Statement and five new items.
* PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
** CONSORT: Consolidated Standards of Reporting Trials
44 Posters Presented at the 17th Annual Meeting of ISMPP
ISMPP members presented 44 posters at the virtual 17th Annual Meeting of ISMPP, April 12-14, 2021. The posters address various relevant topics, including artificial intelligence, equity/diversity/inclusion, plain language summaries, scientific congresses, and social media and metrics. The posters are publicly accessible through June 30, 2021, on the ISMPP Poster Platform, sponsored by Envision Pharma Group. The posters will then be available to only ISMPP members in the Annual Meeting Archive on the Society’s website. The abstracts were published on April 12, 2021, as a supplement in Current Medical Research and Opinion (CMRO).
Poster # | Poster Category | Poster Title | Poster Authors |
1 | Artificial Intelligence (AI) | Artificial intelligence derived literature searches can provide more relevant data, more quickly than traditional reference databases: A case study | Matthew Michelson, Rajni Dogra, Noah Goldberg |
2 | Artificial Intelligence (AI) | Evolving congress competitive intelligence with artificial intelligence: Embracing change and setting trends | Jennifer Ghith, Cheryl Truchan, Zena Askerova, Dheepa Chari, Raj Patel, Vivekanandan Mathivanan |
4 | Artificial Intelligence (AI) | Sentiment analysis of Altmetric data using a human-augmented, artificial intelligence (AI) approach | Matthew Lewis, Ricky Li, Matthew Booth, Mark Latymer, Cecilia Borlenghi, Michelle Kissner |
5 | Contemporary Topics | Authorship inflation in selected clinical trial publications 2012-2020 | Jeffrey W. Clemens, Brian S. Comer |
6 | Contemporary Topics | An analysis of medical publications in the LATAM region: Focus on Brazil, Mexico, and Argentina | Saudha Parthasarathy, Jessica Martin, Susan Ryan, Paulo Mendes |
7* | Contemporary Topics | Digital innovation in clinical trials: use of wearable technology to monitor activity (Encore) | Eve Blumson, Sarah Lambert, Laura Moore, Nikki Kendrick |
8 | Contemporary Topics | Healthcare professionals (HCPs)’ utilization of sources and channels to obtain medical information: opportunities for Medical Affairs (MA) | Rachel No, Jane Shafir Oreper, Jessica McDaniel, Payal Parikh-Patel |
9 | Contemporary Topics | Inclusion of ORCID IDs in pharma-affiliated publications | Sarah Sabir, Laura Dormer, Joanne Walker, Paul Farrow |
10 | Contemporary Topics | Knowledge, experience, challenges, and development needs of Chinese medical publication professionals versus global standards: Updated 2020 results of an online survey | Yutao Lin, Zhigang Ma, Yilin Ge, Peiyu Li, Ying Wang, Zhihua Wu, Xinlei Yu |
11** | Contemporary Topics | A review process for scientific publications to protect the privacy of clinical study participants (Encore) | Colin McKinnon, Valérie Philippon, Friedrich Maritsch, Ingeborg Cil, Jesse Potash, Borislava Pavlova |
12 | Contemporary Topics | The shift to virtual clinical trial recruitment: expanding access during a pandemic | Bill Paquin, Bob MacMillan, Yvette Gaudreau, Kirsten Cullen, Natasha Lockwood, Lindsey Antis |
13 | Contemporary Topics | Trends in the use of omnichannel approaches to transform publication planning—results of a cross-sectional survey of medical publications professionals | William Fazzone, Jessica Bessler, Crystal Darby, Alex Loeb, Jim Lothrop, Adam Ruth, Nancy Sladicka |
14 | Data Sharing | How openly accessible is pharma-sponsored research? An informatics approach (Encore) | Tim Koder, Harry Freeman, Steph Macdonald, Slávka Baróniková, Larisa Miller, Valérie Philippon, Tom Rees |
15 | Data Sharing | Researchers’ priorities for data sharing | Sara Rouhi, Lauren Cadwallader, Iain Hrynaszkiewicz, James Harney |
16 | Equity, Diversity & Inclusion | Hidden in plain sight? Identifying patient authors | Jacqui Oliver, Dawn Lobban, Laura Dormer, Joanne Walker, Richard Stephens, Karen Woolley |
17 | Equity, Diversity & Inclusion | “It’s easier when you know how…” A publications training course for patient advocates, co-created by patient advocates and publication professionals | Karen L. Woolley, Jan Geissler, Tamás Bereczky, Amanda Boughey, Zack Pemberton-Whiteley, Thomas Gegeny, Dawn Lobban |
18 | Equity, Diversity & Inclusion | Sex and gender diversity trends in clinical trials | Namita Satija, Jaclyn Mironov, Reem Berro, Holly Crenca, Courtney Laney, Nik Sanyal, Elizabeth Yannette, Pauline Ng |
19 | Equity, Diversity & Inclusion | Words matter: An examination of word choices in reporting patient demographics | Gabrielle J. Knafler, Margit Rezabek, Meryl Mandle, Linda Wagner |
20 | Plain Language Summaries | Are plain language summaries of health economic publications needed for patients and non-expert audiences? (Encore) | Elizabeth Harvey, Zoe Blumer, Jon Carthy, Suki Kandola, Paola Kruger, Kristyn Morgan, Simon R. Stones, Karen Woolley |
21 | Plain Language Summaries | Current state and challenges for plain-language summary development in Japan | Clarinda Cerejo, Sarayu Pai, Haruko Isomura, Yumi Ioi, Ken-Ichi Setsukinai, Nobuhiko Ishizuka |
22*** | Plain Language Summaries | Guidance for patient engagement in plain language summaries (PLS): Where are we? | Dawn Lobban, Avishek Pal, Laura Dormer, Sheila Khawaja, Lauri Arnstein Williams, Daniela Luzuriaga Ubilla, Anne-Marie Hamoir |
23 | Plain Language Summaries | Publishing plain language summaries of publications as stand-alone journal articles: Publisher’s case study (Encore) | Joanne Walker, Laura Dormer |
24 | Preprints | Assessment of use of preprint articles in reporting news in the COVID-19 era (Encore) | Ben Caldwell, Graham Allcock, Sophie Walton, Nikki Kendrick |
25 | Preprints | Current trends in pharmaceutical industry-affiliated preprints (Encore) | Susan Wieting, Sunita Setlur, Ericka Bueno, Nicolas Bertheleme, Kim Wager, Valérie Philippon |
26 | Preprints | Oncology journal policies on preprint servers: Clarity or ambiguity? (Encore) | Mia Cahill, Matthew Booth, Robert Kingston, Matthew Lewis |
27 | Preprints | Survey on preprint servers: The what, how and who (Encore) | Matthew Booth, Mia Cahill, Robert Kingston, Matthew Lewis |
28 | Scientific Congresses | Are audiences changing in the digital congress era? Findings from publicly available data | Aaron Keeling, Helen Chambers, Isabel Haber, Katie Hamilton, Beverley Wilson, Danielle Sheard |
29**** | Scientific Congresses | Comparison of the carbon costs of in-person and virtual conferences – lessons from the coronavirus pandemic (Encore) | William T Gattrell, Aurélie Barraux, Sam Comley, Michael Whaley, Nicholas Lander |
30 | Scientific Congresses | Evaluation of QR code use in in-person versus virtual congresses for posters in the COVID-19 era: Are we reaching our audiences? | Gill Hill, Sunita Setlur, Ericka Bueno, Gina D’Angelo, Roseanne Girnary, Susan Wieting |
31 | Scientific Congresses | Impact of COVID-19 pandemic on medical congresses (Encore) | Valérie Philippon, Shailesh Y Desai, Jessica Tyler, Fran Young, Susan Wieting, Dikran Toroser, Jesse Potash, Colin A McKinnon |
32 | Scientific Congresses | The impact of the COVID-19 pandemic on scientific conferences: A survey study | Lisa Feder, Lauren Mitchell, Larry Radican |
33 | Scientific Congresses | Transition of physical to virtual congresses during the COVID-19 pandemic – impacts and implications | Weiyi Li, Adrienne A. Aiello, Åsa Lommelé, Mary Kunjappu, Cody Longbrake, Shweta Rane |
34 | Scientific Congresses | Perceived value of encore medical abstracts and presentations (Encore) | Suzanne M. Douthwaite, Karen M. Spach, Nicole A. Meinel |
35 | Scientific Congresses | Reform and enhancement of scientific posters: What was the extent of innovation in 2020? (Encore) | Elin Pyke, Sabrina de Courcy, Laura Smart, Rachel Patel, Ben Clarke |
36 | Social Media & Metrics | @ISMPP: Embracing Twitter, creating (more) opportunities? | Andy Shepherd, Kathryn Coles, Brian Grice, Karen L. Woolley |
38 | Social Media & Metrics | Assessing the success of a scientific communication platform: Identifying and implementing specific metrics | Gretchen S. Chidester, Boyd B. Scott, Keith J. Gaddie, Ken Truman, Jamie L. Kistler |
39 | Social Media & Metrics | Current trends in the use of social media to disseminate pharmaceutical publications | Stephen Towers, Paul Kaiser, Katheryn Mazzilli, Jeff Hannah, Kyle Lambe, Kristen Oeltjen-Bruns, Dina Marenstein |
40 | Social Media & Metrics | Do traditional Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs) exist in the same or different communities? (Encore) | Andy Shepherd, Chirag Jay Patel, Xiao Li, Matt Lewis |
41 | Social Media & Metrics | Is there a blueprint for biotech pre-launch peer-review publication planning? (Encore) | Matthew Lewis, Samuel Falsetti, Rachel Hatfield, Alex Taylor, David Dible, Matthew Booth |
42 | Social Media & Metrics | Social media in medical publishing: A comparative review | Cindy Busch, Nicole Coolbaugh, Shaina Gilstein, Barbara Kuri, Stephanie Lit, Monica Salvadore, Philip Sjostedt |
43 | Social Media & Metrics | Tool to measure real-world publication reach, engagement and impact (Encore) | Tom Rees, Heather Lang, William T Gattrell |
44 | Social Media & Metrics | Understanding the impact of social media engagement with clinical publications | Michelle Kissner, Nicolle Stinley, Andy Shepherd |
45 | Social Media & Metrics | Use of digital content, platforms and digital online leaders: A survey of US healthcare professionals | Valerie Moss, Siobhan Peterson, Michelle Collins |
46 | Social Media & Metrics | Utilizing open social media channels to expand publication reach | Dheepa Chari, Jennifer Ghith, Raj Patel, Torrey Volkman, Scott Houck, Leslie Rotz |
* Best Visual Communication poster award
** Publication Star poster award (tie)
*** Best Practice poster award
**** Best Original Research poster award AND Publication Star poster award (tie)
Note: 2 abstracts withdrawn (poster numbers 3 and 37)
Record 42 Posters Presented at 2021 European Meeting of ISMPP
A record 42 posters were presented by ISMPP members at the virtual 2021 European Meeting of ISMPP, January 26-27, covering such current topic areas as authorship, COVID-19, digital/social media, enhanced communication, preprints, and patient advocacy. The posters are accessible to ISMPP members only in the 2021 European Meeting Archive on the ISMPP website. The abstracts were published on April 12, 2021, as a supplement in Current Medical Research and Opinion (CMRO).
Poster # | Poster Category | Poster Title | Poster Authors |
1 | Authorship | Authorship practices for publications affiliated to a mid-sized pharmaceutical company | Heather Lang, Laura Drought, Phoebe Hobbs, William T Gattrell |
2 | Contemporary Topics | Digital innovation in clinical trials: Use of wearable technology to monitor activity | Eve Blumson, Sarah Lambert, Laura Moore, Nikki Kendrick |
3 | COVID-19 | Scientific communications during COVID 19: A survey of Spanish authors | Pablo Pons, William Dolben, Laura Pérez |
4 | COVID-19 | Publications during COVID 19: Focus on Spanish authors | William Dolben, Pablo Pons, Laura Pérez |
6 | COVID-19 | Impact of COVID-19 pandemic on medical congresses | Valérie Philippon, Shailesh Y Desai, Jessica Tyler, Fran Young, Susan Wieting, Dikran Toroser, Jesse Potash, Colin A McKinnon |
7 | COVID-19 | Comparison of the carbon costs of in-person and virtual conferences – lessons from the coronavirus pandemic | William T Gattrell, Aurélie Barraux, Sam Comley, Michael Whaley, Nicholas Lander |
8 | COVID-19 | Evaluation of poster presentations at virtual conferences | Andrew Short, Nina C Kennard, Emma Parfrementa, Jason McDonough |
9 | COVID-19 | The impact of the increased need for digital activities due to the COVID-19 pandemic: A survey of medical communications professionals | Matthew Reynolds, Oyinkan Adesakin, Jon Viney, Sarah Thomas |
10 | COVID-19 | The role of scientific publications in driving public discussion around treatments for COVID-19 | Ashley J. Porter, Matt Gooding, Gerard Mortimer, Islay Steele, Rachel Johnson, Fiona J. Plunkett |
11 | Digital/Social Media | Do traditional Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs) exist in the same or different communities? | Andy Shepherd, Chirag Jay Patel, Xiao Li, Matt Lewis |
12 | Digital/Social Media | Podcasts for delivery of medical education | Julliana Newman, Andrew Liew, Jon Bowles, Kelly Soady, Steven Inglis |
13 | Digital/Social Media | Maximizing publication impact through stakeholder collaboration, digital enhancements, external communications and social media: A case study | Caroline Halford, Lydia Alborn, Victoria Glasson, Alison Chisholm, William Gattrell |
14 | Digital/Social Media | Using social media to drive engagement with scientific posters | Alison Lovibond, Sara Shaw, John McGuire, Amy Mehta, Mark Lydiatt |
15 | Digital/Social Media | Consumption of publication content—mapping the audience journey to inform omnichannel planning | Adam Ruth, Ravi Subramanian, Joelle Suchy, Nancy Sladicka, Suzanne Van De Water, Ann Loftus, Beth McGhee, William Fazzone, Jim Lothrop, Laurie Valan |
16 | Enhanced Communication | Reform and enhancement of scientific posters: What was the extent of innovation in 2020? | Elin Pyke, Sabrina de Courcy, Laura Smart, Rachel Patel, Ben Clarke |
17 | Enhanced Communication | AI-based Scientific Editing Tool (SET) aids in improving the linguistic quality of scientific documents and accelerates publication | Trinka D’Cunha, Pinki Rajeev |
18 | Enhanced Communication | Can novel adaptations that increase two-way scientific exchange save posters from being overlooked at medical congresses? | John McGuire, Alison Lovibond, Amy Mehta, Sara Shaw, Mark Lydiatt |
19 | Good Publication Practice | Challenges of simultaneous publications: Journal and congress perspectives | Kris Schuler, Rhyomi Sellnow, Todd Parker |
20 | Good Publication Practice | Plagiarism detection software – Is the net too wide? | Rezan Sahinkaya, Amanda C. Vreeland, Heidi Reinholdt, Christopher Barnes, Dina Marenstein, William Sinkins |
21 | Good Publication Practice | Awareness of journal credibility, publication practices and predatory journals: Findings from a company survey | Nisha F Sheikh, Anna V Popova |
22 | Good Publication Practice | A review process for scientific publications to protect the privacy of clinical study participants | Colin McKinnon, Valérie Philippon, Friedrich Maritsch, Ingeborg Cil, Jesse Potash, Borislava Pavlova |
23 | Good Publication Practice | Perceived value of encore medical abstracts and presentations | Suzanne M. Douthwaite, Karen M. Spach, Nicole A. Meinel |
24 | Good Publication Practice | How often are negative trial data being published? An analysis of colorectal cancer studies | Ciaran Robert, Frederick Wright, Helen Bristow, Judy Brownsword, Alexander Thomas Hardy, Andrew Noble |
25 | Good Publication Practice | Is there a blueprint for biotech pre-launch peer-review publication planning? | Matthew Lewis, Samuel Falsetti, Rachel Hatfield, Alex Taylor, David Dible, Matthew Booth |
26 | Good Publication Practice | Understanding copyright challenges in the evolving virtual environment | Laura McGovern, Helena Bailes, Jonathan Brennan, Priya Sagoo, Zoe Preston |
27 | Good Publication Practice | Impact of requirements to register and report results of all clinical trials: What is being published where? | Georgina Barr, Sara Black, Hannah Brazier, Jill Powell, Jon Viney, Sophie Hopkins |
28 | Good Publication Practice | Improving the use of ORCID: A publisher case study | Laura Dormer, Sarah Sabir, Joanne Walker, Paul Farrow |
29 | Metrics | Does publication impact vary by disease indication and publication type? A deep-dive using a novel, value-based, publication metric framework: EMPIRE Index | Avishek Pal, Tom Rees |
30 | Metrics | Tool to measure real-world publication reach, engagement and impact | Tom Rees, Heather Lang, and William T Gattrell |
31 | Open Access | Costs and savings associated with publishing open access: A case series | Simon Page, Ghiesla Nel, Abbie Pound |
32 | Open Access | How openly accessible is pharma-sponsored research? An informatics approach | Harry Freeman, Steph Macdonald, Slávka Baróniková, Larisa Miller, Valérie Philippon, Tim Koder, Tom Rees |
33 | Open Access | Baseline assessment of open access publishing for Boehringer Ingelheim sponsored research | Louise Roch, Kumari Priyanka, Daniel Portsmouth, Tom Grant |
34 | Patient Advocacy | How readable are plain language summaries? | Tony Ferrar, Emma Conran |
35 | Patient Advocacy | Plain language summaries of publications: What key questions do we need to address? | Dawn Lobban, Jason Gardner, Rob Matheis, on behalf of the ISMPP PLS Perspectives Working Group |
36 | Patient Advocacy | Is the patient voice being heard in peer-reviewed medical publications? | Sarah Lambert, Nikki Kendrick, Danyal Hami, Simon Stones |
37 | Patient Advocacy | Publishing plain language summaries of publications as stand-alone journal articles: A publisher’s case study | Joanne Walker, Laura Dormer |
38 | Patient Advocacy | Are plain language summaries of health economic publications needed for patients and non-expert audiences? | Elizabeth Harvey, Zoe Blumer, Jon Carthy, Suki Kandola, Paola Kruger, Kristyn Morgan, Simon R. Stones, Karen Woolley |
39* | Preprints | Use of the preprint server medRxiv for industry-sponsored research: COVID-19 versus non-COVID-19 research | Lisa Jolly, Shalini Murthy, Nichola Gokool |
40** | Preprints | Assessment of the abuse of preprint articles for the sensationalisation of news in the Covid-19 era | Graham Allcock, Sophie Walton, Nikki Kendrick |
41 | Preprints | Survey on preprint servers: The what, how and who | Matthew Booth, Mia Cahill, Robert Kingston, Matthew Lewis |
42 | Preprints | Oncology journal policies on preprint servers: Clarity or ambiguity? | Mia Cahill, Matthew Booth, Robert Kingston, Matthew Lewis |
43 | Preprints | Analysis of pharmaceutical industry-affiliated preprints in the medRxiv repository | Susan Wieting, Sunita Setlur, Ericka Bueno, Nicolas Bertheleme, Kim Wager, Valérie Philippon |
* Most Valuable Digital Poster Format or Enhancement poster award
** Most Reflective of Meeting Theme poster award AND Best Original Research poster award
Note: 1 abstract withdrawn (poster number 5)